Pay in 4 interest-free payments of $6.90 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
BPC-157 (Body Protection Compound-157) research peptide for tissue regeneration studies
Human evidence - Phase 3 TRANSCEND-T2D-1 (Eli Lilly, March 19, 2026) 537 adults with type 2 diabetes, randomized 1:1:1:1 to retatrutide 4, 9, or 12 mg or placebo
the National Institute of Mental Health (grants 5R01MH097216-07, MH135860, MH-094268, MH-107730, MH-129480 and MH-136297), both of the National Institutes of Health
Rotate injection sites to prevent lipohypertrophy (a buildup of fat tissue at the injection site from repeated use)
contact your prescriber for instructions on adjusted dosing or vial replacement
US$ 27.08
US$ 24.55
US$ 22.61
US$ 24.35
US$ 25.10
